NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression
(NasdaqGM:STIM), MALVERN, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced two peer-reviewed publications in the inaugural edition of the Transcranial Magnetic Stimulation journal. The first provides compelling […]